Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-beta monoclonal antibody, NIS793, in combination with Spartalizumab in adult patients with advanced tumors
How can I measure whether the size changed
However, because each brand has distinct indications, dosing, and availability, understanding the differences is essential before starting treatment
This study indicated that riboflavin could significantly decrease 8-hydroxydeoxyguanosine (a biomarker for oxidative DNA damage) in aneurysm walls (Reference Yu, Morimoto and Yu32)
Oral alternative (if stable & no urgent need for IV): immediate-release nifedipine 10 mg PO, repeat once if needed
Both compounds are being studied primarily for their effect on body weight and metabolic health, but the reported benefits extend beyond the scale